Adagio Medical (ADGM) Projected to Post Earnings on Monday

Adagio Medical (NASDAQ:ADGM) is expected to announce its results before the market opens on Monday, April 6th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter.

Adagio Medical (NASDAQ:ADGM) last announced its quarterly earnings data on Friday, March 27th. The company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.31) by $0.10.

Adagio Medical Stock Performance

ADGM opened at $1.25 on Friday. The company has a fifty day moving average of $1.05 and a 200 day moving average of $1.16. The company has a debt-to-equity ratio of 1.70, a quick ratio of 0.68 and a current ratio of 2.44. The stock has a market capitalization of $27.76 million, a price-to-earnings ratio of -0.72 and a beta of 0.04. Adagio Medical has a fifty-two week low of $0.63 and a fifty-two week high of $2.87.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Adagio Medical in a research report on Monday, December 22nd. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $4.00.

Hedge Funds Weigh In On Adagio Medical

Several large investors have recently bought and sold shares of ADGM. Alyeska Investment Group L.P. acquired a new position in shares of Adagio Medical in the 4th quarter valued at $1,206,000. ADAR1 Capital Management LLC acquired a new stake in shares of Adagio Medical during the 4th quarter worth $1,206,000. Armistice Capital LLC purchased a new position in shares of Adagio Medical in the 4th quarter worth $497,000. Hudson Bay Capital Management LP acquired a new position in Adagio Medical in the fourth quarter valued at $308,000. Finally, Adage Capital Partners GP L.L.C. boosted its holdings in Adagio Medical by 18.9% in the fourth quarter. Adage Capital Partners GP L.L.C. now owns 1,258,501 shares of the company’s stock valued at $1,309,000 after acquiring an additional 200,000 shares during the last quarter. Hedge funds and other institutional investors own 48.08% of the company’s stock.

About Adagio Medical

Adagio Medical, Inc (NASDAQ: ADGM) is a medical device company focused on the development and commercialization of a noninvasive system for monitoring intracranial pressure (ICP). The company’s proprietary technology uses tympanic membrane displacement to provide clinicians with real-time estimates of ICP without the risks associated with invasive catheter methods. This approach is designed to improve patient safety, reduce complications, and streamline neurological monitoring in acute and critical care settings.

At the core of Adagio Medical’s pipeline is its ADGM System, which is intended for use in hospitals, emergency departments, and other clinical environments where rapid and accurate assessment of ICP is crucial.